Advanced Proteome Company Top Insiders
| APTCF Stock | USD 0.0002 0.00 0.00% |
Advanced Proteome employs about 11 people. The company is managed by 2 executives with a total tenure of roughly 6 years, averaging almost 3.0 years of service per executive, having 5.5 employees per reported executive. Examination of Advanced Proteome's management performance can provide insight into the company performance.
| Paul Woodward CEO CEO, Pres |
Advanced |
Advanced Proteome Management Team Effectiveness
The company has return on total asset (ROA) of (1.0654) % which means that it has lost $1.0654 on every $100 spent on assets. This is way below average. Advanced Proteome's management efficiency ratios could be used to measure how well Advanced Proteome manages its routine affairs as well as how well it operates its assets and liabilities.Advanced Proteome Workforce Comparison
Advanced Proteome Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 321. Advanced Proteome holds roughly 11.0 in number of employees claiming about 3% of equities under Health Care industry.
Advanced Proteome Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Advanced Proteome Price Series Summation is a cross summation of Advanced Proteome price series and its benchmark/peer.
Advanced Proteome Notable Stakeholders
An Advanced Proteome stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Advanced Proteome often face trade-offs trying to please all of them. Advanced Proteome's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Advanced Proteome's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Paul Woodward | CEO, Pres | Profile | |
| Martin Woodward | S Director | Profile |
About Advanced Proteome Management Performance
The success or failure of an entity such as Advanced Proteome often depends on how effective the management is. Advanced Proteome management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Advanced management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Advanced management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. Advanced Proteome operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Advanced Proteome Workforce Analysis
Traditionally, organizations such as Advanced Proteome use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Advanced Proteome within its industry.Advanced Proteome Manpower Efficiency
Return on Advanced Proteome Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Income Per Employee | 69.1K | |
| Net Income Per Executive | 379.8K |
Complementary Tools for Advanced Pink Sheet analysis
When running Advanced Proteome's price analysis, check to measure Advanced Proteome's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Proteome is operating at the current time. Most of Advanced Proteome's value examination focuses on studying past and present price action to predict the probability of Advanced Proteome's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Proteome's price. Additionally, you may evaluate how the addition of Advanced Proteome to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |